Gabelli Healthcare & Wellness Rx Trust GRX
We take great care to ensure that the data presented and summarized in this overview for Gabelli Healthcare & WellnessRx Trust is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GRX
View all-
Saba Capital Management, L.P. New York, NY1.85MShares$18.9 Million0.43% of portfolio
-
Wells Fargo & Company San Francisco, CA352KShares$3.6 Million0.0% of portfolio
-
Mario Gabelli Gamco Investors, Inc. Et Al | Rye, Ny309KShares$3.16 Million0.04% of portfolio
-
Cetera Investment Advisers Schaumburg, IL225KShares$2.3 Million0.01% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN200KShares$2.05 Million0.05% of portfolio
-
Morgan Stanley New York, NY189KShares$1.94 Million0.0% of portfolio
-
Blue Bell Private Wealth Management, LLC168KShares$1.72 Million0.37% of portfolio
-
Bennicas & Associates, Inc.165KShares$1.69 Million1.08% of portfolio
-
Aqr Arbitrage LLC Greenwich, CT158KShares$1.62 Million0.08% of portfolio
-
Beacon Pointe Advisors, LLC Newport Beach, CA131KShares$1.34 Million0.02% of portfolio
Latest Institutional Activity in GRX
Top Purchases
Top Sells
About GRX
The Gabelli Healthcare and Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.
Insider Transactions at GRX
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 04
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,364
+0.29%
|
$53,640
$10.36 P/Share
|
Nov 01
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,448
+0.19%
|
$34,480
$10.33 P/Share
|
Oct 24
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,441
+0.56%
|
$104,410
$10.59 P/Share
|
Sep 27
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,196
+0.06%
|
$13,156
$11.1 P/Share
|
Sep 26
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,345
+0.61%
|
$124,795
$11.12 P/Share
|
Aug 26
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,453
+0.35%
|
$64,530
$10.88 P/Share
|
Aug 23
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
951
+0.05%
|
$9,510
$10.8 P/Share
|
Aug 22
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
4,205
+0.23%
|
$42,050
$10.69 P/Share
|
Aug 19
2024
|
Mario J Gabelli Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+1.59%
|
$50,000
$10.76 P/Share
|
Aug 09
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
19,481
+1.06%
|
$194,810
$10.47 P/Share
|
Aug 08
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
811
+0.05%
|
$8,110
$10.4 P/Share
|
Aug 07
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
20,714
+1.14%
|
$207,140
$10.22 P/Share
|
Aug 02
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,200
+0.07%
|
$12,000
$10.43 P/Share
|
Jul 31
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,560
+0.53%
|
$95,600
$10.49 P/Share
|
Jul 30
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
24,605
+1.37%
|
$246,050
$10.42 P/Share
|
Jul 29
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,903
+0.62%
|
$109,030
$10.34 P/Share
|
Jul 26
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
30,734
+1.74%
|
$307,340
$10.29 P/Share
|
Jul 25
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
36,371
+2.09%
|
$363,710
$10.19 P/Share
|
Jul 24
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
18,095
+1.07%
|
$180,950
$10.08 P/Share
|
Jul 23
2024
|
Saba Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
22,571
+1.35%
|
$225,710
$10.08 P/Share
|
Last 12 Months Summary
Open market or private purchase | 889K shares |
---|
Other acquisition or disposition | 981K shares |
---|